André-Michel Ballester

André-Michel Ballester

Private Equity Investor at
ArchiMed SAS
68 year
Health Technology
Consumer Services
Process Industries

Profile

Currently, André-Michel Ballester is Managing Partner at ArchiMed SAS since 2017 and Managing Partner at North American Science Associates LLC starting in 2025.
Formerly, the roles include Chief Executive Officer & Director at Sorin SpA from 2007 to 2015, Chief Executive Officer & Director at LivaNova Plc from 2015 to 2016, Chairman at Bomi Italia SpA and Suan Farma SA, Independent Director at Mauna Kea Technologies SA from 2014 to 2015, Director at IMI Intelligent Medical Implants AG, Director at Carmat SA from 2009 to 2010, Independent Director at Pixium Vision SA, Director at Natus Medical, Inc., Lead Independent Director at DiaSorin SpA, Vice President-Europe, Middle East & Africa Region at Edwards Lifesciences Corp.
from 2000 to 2004, and President-CardioVascular Group at Baxter Cardiovascular Group.
Education includes an MBA from INSEAD in 1983 and undergraduate studies at École centrale de Lille.

André-Michel Ballester active positions

CompaniesPositionStart
Private Equity Investor 01/01/2017
Corporate Officer/Principal 24/02/2025

Former positions of André-Michel Ballester

CompaniesPositionEnd
LIVANOVA PLC Chief Executive Officer 31/12/2016
MAUNA KEA TECHNOLOGIES Director/Board Member 17/12/2015
SORIN SPA Chief Executive Officer 01/10/2015
EDWARDS LIFESCIENCES CORPORATION Corporate Officer/Principal -
Chairman -
See the detail of André-Michel Ballester's experience

Training of André-Michel Ballester

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Process Industries

Health Technology

Consumer Services

Distribution Services

Commercial Services

Health Technology

Transportation

Baxter Cardiovascular Group

Health Technology

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. André-Michel Ballester